Biocon Profit & Loss Annual

Trade
BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | Sector: Biotechnology & Drugs
336.35 +5.15 (1.55%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 14,755.7011,174.208,184.007,143.10
Total Revenue 14,755.7011,174.208,184.007,143.10
Costof Revenue Total 4,897.904,350.403,205.502,651.80
Gross Profit 9,857.806,823.804,978.504,491.30
Selling/ General/ Admin Expenses Total 2,664.102,946.602,576.302,349.00
Depreciation/ Amortization 1,568.801,113.10814.20715.10
Unusual Expense( Income) -93.7074.4081.20-172.30
Other Operating Expenses Total 3,895.00524.80-100.5087.20
Total Operating Expense 12,932.109,622.507,079.506,025.80
Operating Income 1,823.601,551.701,104.501,117.30
Interest Inc( Exp) Net- Non- Op Total -10,586.00-6,533.00-1,198.00-488.00
Other Net 760.203.900.706.50
Net Income Before Taxes 1,525.20897.10983.101,067.70
Provisionfor Income Taxes 227.40254.10211.50221.50
Net Income After Taxes 1,297.80643.00771.60846.20
Minority Interest -275.30-180.30-123.20-105.70
Net Income Before Extra Items 1,022.50462.70648.40740.50
Net Income 1,022.50462.70648.40740.50
Income Availableto Com Excl Extra Ord 1,022.50462.70648.40740.50
Income Availableto Com Incl Extra Ord 1,022.50462.70648.40740.50
Diluted Net Income 1,022.50462.70648.40740.50
Diluted Weighted Average Shares 119.73119.59119.64119.63
Diluted EPS Excluding Extra Ord Items 8.543.875.426.19
DPS- Common Stock Primary Issue 0.501.500.500.00
Diluted Normalized EPS 7.874.355.975.10
Research Development -6,132.005,028.003,950.00
Gain( Loss)on Saleof Assets --52.00-23.00-73.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts